EP 3151822 A4 20171122 - FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
Title (en)
FIXED DOSE COMBINATION FOR PAIN RELIEF WITHOUT EDEMA
Title (de)
KOMBINATION MIT FIXER DOSIERUNG ZUR SCHMERZLINDERUNG OHNE ÖDEM
Title (fr)
COMBINAISON À DOSE FIXE UTILISABLE EN VUE DU TRAITEMENT DE LA DOULEUR ET N'INDUISANT PAS D'OEDÈME
Publication
Application
Priority
- US 201462009300 P 20140608
- US 201462023962 P 20140714
- US 2015011148 W 20150113
- US 2015034706 W 20150608
Abstract (en)
[origin: WO2015191460A1] Methods for individualized therapy of arthritic pain using a non-steroidal anti-inflammatory drug (iCOX-2 inhibitor). Said methods comprise basing COX-2 inhibitor dose on each patient's pharmacokinetic response to said COX-2 inhibitor. Provided is a composition for treating pain without inducing edema comprising a COX-2 inhibitor and a diuretic, wherein the composition is administered in a fixed-dose combination.
IPC 8 full level
A61K 9/00 (2006.01); A61K 31/415 (2006.01); A61K 31/549 (2006.01); A61K 31/635 (2006.01); A61K 45/06 (2006.01); A61P 7/10 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP KR)
A61K 31/196 (2013.01 - KR); A61K 31/415 (2013.01 - EP KR); A61K 31/4245 (2013.01 - KR); A61K 31/54 (2013.01 - KR); A61K 31/549 (2013.01 - EP KR); A61K 31/616 (2013.01 - KR); A61K 45/06 (2013.01 - EP KR); A61P 7/10 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 29/02 (2017.12 - EP); A61P 43/00 (2017.12 - EP); A61K 2300/00 (2013.01 - KR)
Citation (search report)
- [XY] WO 2006058073 A2 20060601 - TRANSFORM PHARMACEUTICALS INC [US], et al
- [XY] WO 2009154944 A2 20091223 - HOYLE PETER C [US], et al
- [A] MOORE R ANDREW ET AL: "Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports", ARTHRITIS RESEARCH, CURRENT SCIENCE, LONDON, GB, vol. 7, no. 3, 24 March 2005 (2005-03-24), pages R644 - R665, XP021011594, ISSN: 1465-9905, DOI: 10.1186/AR1704
- [T] SANJIVE QAZI ET AL: "Abstract 2597: Celecoxib fixed dose combinations - patient level data analyses", CANCER RESEARCH, vol. 77, no. 13 Supplement, 1 July 2017 (2017-07-01), US, pages 2597 - 2597, XP055416583, ISSN: 0008-5472, DOI: 10.1158/1538-7445.AM2017-2597
- [T] W WANG ET AL: "Poster Number 110: Patient-level Data Analysis Revealed the Real Incidence and Impact of Celecoxib on Edema", CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, vol. 6, no. Suppl 1, 1 September 2017 (2017-09-01), pages 69 - 70, XP055416585, DOI: 10.1002/cpdd.385
- See references of WO 2015191460A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2015191460 A1 20151217; AU 2015274895 A1 20170202; AU 2015274908 A1 20170119; CA 2956897 A1 20151217; CA 2956899 A1 20151217; CN 106572984 A 20170419; CN 106572985 A 20170419; EP 3151822 A1 20170412; EP 3151822 A4 20171122; EP 3151823 A1 20170412; EP 3151823 A4 20171122; JP 2017517529 A 20170629; JP 2017517575 A 20170629; KR 20160091348 A 20160802; KR 20160091349 A 20160802; TW 201642854 A 20161216; TW 201642906 A 20161216; WO 2015191473 A1 20151217; WO 2015191473 A9 20160324
DOCDB simple family (application)
US 2015034706 W 20150608; AU 2015274895 A 20150608; AU 2015274908 A 20150608; CA 2956897 A 20150608; CA 2956899 A 20150608; CN 201580040734 A 20150608; CN 201580042156 A 20150608; EP 15806490 A 20150608; EP 15807276 A 20150608; JP 2016571720 A 20150608; JP 2017516649 A 20150608; KR 20167015173 A 20150608; KR 20167015176 A 20150608; TW 105109706 A 20160328; TW 105109708 A 20160328; US 2015034738 W 20150608